NASDAQ
Inovio Pharmaceuticals, Inc. (INO) has a current ratio of 1.40x as of Monday, May 25, 2026. This represents a 65.95% decrease compared to its 12-month average of 4.11x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.